The company was incorporated in the People's Republic of China (“PRC”) on 15 March 2013 as a limited liability company. On 21 July 2021, the Company was converted into a joint stock company with limited liability under the Company Law of PRC.
The Company and its subsidiaries was a medical device company with a main focus on the field of cryoablation minimally-invasive interventional treatment. Based on the Group's liquid nitrogen cryoablation technology, it mainly engages in research and development of cardiovascular innovation minimally invasive based on the cryomedical technology and other related medical products.
Headquarters
Room 1901, 19/F, Lee Garden One, 33 Hysan Avenue, Hong Kong
Hong Kong; Hong Kong;
Contact Details: Purchase the Cryofocus Medtech (Shanghai) Co. Ltd. report to view the information.
Website: http://www.cryofocus.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service